REPL
Replimune Group, Inc.
stock NASDAQ

My point is not that REPL is in the same space, just that the FDA seems to be having an identity crisis and it worries some investors (like me) that they are not the level playing field umpire they need to be. 

$CAPR and $REPL were previously rejected by FDA. There is nothing there that translates to this space. $CAPR is a fraudulent company. Sell-side analyst opinions suffer from group think. There is one or two that are worth watching like Jefferies. I highly doubt Wells Fargo report is moving the market lol. $XBI is in a pullback since reaching highs of $165. Probably explains the weakness overall.

I think the risk off in the macro is not helpful. FDAs on again off again with stocks like REPL is causing pause on trying to figure out exactly what’s going on inside the FDA. The ATAI acquisition was devastating and the double tap by Wells Fargo was even worse. They basically said CMPS was the worst of the bunch even with approval. The only “up” I see right now is the super low volume which tells me the institutional folks are hanging in for now.
I own a ton of CMPS but I just think we’re gonna see a serious pullback until there’s “no sh!t” good news. 

Careful of that abnormal sell volume today. Everything leaks now that Trump has his FDA guy in.
(Peep REPL decision this morning and its volume yesterday)

REPL Replimune July 30 Adcom links

Look bro, I always follow your posts. Just tell me which one is your pick.
Also, anything on REPL? I thought they had a catalyst coming on August 2nd